Literature DB >> 10334806

The Lys198Asn polymorphism in the endothelin-1 gene is associated with blood pressure in overweight people.

L Tiret1, O Poirier, V Hallet, T A McDonagh, C Morrison, J J McMurray, H J Dargie, D Arveiler, J B Ruidavets, G Luc, A Evans, F Cambien.   

Abstract

There is accumulating evidence that endothelin-1 plays an important role in vascular pathophysiology. Our objective was to examine whether molecular variations at the endothelin-1 locus were involved in susceptibility to myocardial infarction and variation in blood pressure. The entire coding sequence and 1.4 kb of the 5' flanking region were screened. Five polymorphisms were detected, which were genotyped in the ECTIM (Etude Cas-Témoin de l'Infarctus du Myocarde) Study, a multicenter study comparing 648 male patients who had survived a myocardial infarction and 760 population-based controls. The polymorphisms were not associated with myocardial infarction, nor did they contribute to blood pressure levels in the population at large. However, a G/T polymorphism predicting an Lys/Asn change (ET1/C198) strongly interacted (P<0.001) with body mass index in the determination of blood pressure levels. There was a steeper increase of blood pressure with body mass index in carriers of the T allele than in GG homozygotes. As a consequence, the T allele was associated with an increase of blood pressure in overweight subjects (body mass index >/=26 kg/m2), while no significant effect was observed in lean subjects (body mass index <26 kg/m2). To determine whether this finding could be replicated, the ET1/C198 was genotyped in the Glasgow Heart Scan Study, a population-based study including 619 men and 663 women. Subjects homozygous for the T allele had higher resting blood pressure levels than others (P<0.05). A similar interaction between the T allele and body mass index was observed on the maximum blood pressure achieved during a treadmill exercise test (P<0.001). In conclusion, results from 2 independent studies suggest that the ET1/C198 polymorphism is associated with blood pressure levels in overweight people.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10334806     DOI: 10.1161/01.hyp.33.5.1169

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  39 in total

Review 1.  Candidate genes and confirmed genetic polymorphisms associated with cardiovascular diseases: a tabular assessment.

Authors:  Z Tang; R P Tracy
Journal:  J Thromb Thrombolysis       Date:  2001-02       Impact factor: 2.300

Review 2.  Genetic determinants of vascular reactivity.

Authors:  Daniel Henrion; Joelle Benessiano; Marc Iglarz; Ivan Philip; Bernard I Levy
Journal:  Curr Hypertens Rep       Date:  2002-02       Impact factor: 5.369

Review 3.  Context-dependent genetic effects in hypertension.

Authors:  S L Kardia
Journal:  Curr Hypertens Rep       Date:  2000-02       Impact factor: 5.369

Review 4.  Endothelin A receptor antagonists in congestive heart failure: blocking the beast while leaving the beauty untouched?

Authors:  L E Spieker; G Noll; F T Ruschitzka; T F Lüscher
Journal:  Heart Fail Rev       Date:  2001-12       Impact factor: 4.214

5.  Regulation of vascular contractility and blood pressure by the E2F2 transcription factor.

Authors:  Junlan Zhou; Yan Zhu; Min Cheng; Deepika Dinesh; Tina Thorne; Kian Keong Poh; Dongxu Liu; Chantal Botros; Yao Liang Tang; Nichole Reisdorph; Raj Kishore; Douglas W Losordo; Gangjian Qin
Journal:  Circulation       Date:  2009-09-14       Impact factor: 29.690

6.  Interactive influences of ethnicity, endothelin-1 gene, and everyday discrimination upon nocturnal ambulatory blood pressure.

Authors:  Mathew J Gregoski; Sarah G Buxbaum; Gaston Kapuku; Yanbin Dong; Haidong Zhu; Mary Davis; Kelsey Gonto; Frank A Treiber
Journal:  Ann Behav Med       Date:  2013-06

7.  Dysregulated aldosterone secretion in persons of African descent with endothelin-1 gene variants.

Authors:  Jia W Tan; Tina Gupta; Worapaka Manosroi; Tham M Yao; Paul N Hopkins; Jonathan S Williams; Gail K Adler; Jose R Romero; Gordon H Williams
Journal:  JCI Insight       Date:  2017-12-07

Review 8.  Metabolic syndrome and endothelial dysfunction.

Authors:  Alessia Fornoni; Leopoldo Raij
Journal:  Curr Hypertens Rep       Date:  2005-04       Impact factor: 5.369

9.  Pharmacogenetic effect of an endothelin-1 haplotype on response to bucindolol therapy in chronic heart failure.

Authors:  Matthew R G Taylor; Dobromir Slavov; Kurt Humphrey; Lan Zhao; Jennifer Cockroft; Xiao Zhu; Philip Lavori; Michael R Bristow; Luisa Mestroni; Laura C Lazzeroni
Journal:  Pharmacogenet Genomics       Date:  2009-01       Impact factor: 2.089

10.  Investigating the association between K198N coding polymorphism in EDN1 and hypertension, lipoprotein levels, the metabolic syndrome and cardiovascular disease.

Authors:  Steven Wiltshire; Brenda L Powell; Michelle Jennens; Pamela A McCaskie; Kim W Carter; Lyle J Palmer; Peter L Thompson; Brendan M McQuillan; Joseph Hung; John P Beilby
Journal:  Hum Genet       Date:  2008-02-21       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.